Uniformed Services University of the Health Sciencesgrid.265436.0, Bethesda, Maryland, USA.
Henry M. Jackson Foundation for Military Medicine, Rockville, Maryland, USA.
J Bacteriol. 2022 Oct 18;204(10):e0024722. doi: 10.1128/jb.00247-22. Epub 2022 Sep 12.
The disease-producing capacity of the opportunistic pathogen Enterococcus faecalis is enhanced by the ability of the bacterium to evade killing by antimicrobial agents. Survival of E. faecalis in the presence of the human antimicrobial enzyme lysozyme is mediated in part by the site 2 metalloprotease Eep; however, a complete model of enterococcal lysozyme resistance has not been elucidated. To better understand the molecular basis for lysozyme resistance in E. faecalis, we analyzed Δ suppressor mutants that acquire resistance to lysozyme through mutation of the gene , a predicted teichoic acid biosynthesis-encoding gene located within the variable region of the enterococcal polysaccharide antigen () locus. Sequence comparisons revealed that is most similar to the cytidine-5'-diphosphate (CDP)-glycerol:poly-(glycerolphosphate)glycerophosphotransferase TagF from Staphylococcus epidermidis. Inactivation of in both the wild-type and Δ genetic backgrounds was sufficient to increase the resistance of E. faecalis OG1RF to lysozyme. Minimal amounts of -acetylgalactosamine were detectable in cell wall carbohydrate extracts of deletion mutants, and this was associated with a reduction in negative cell surface charge. Targeted disruption of was also associated with increased susceptibility to the antibiotic polymyxin B and membrane-targeting detergents and decreased susceptibility to the lantibiotic nisin. This work implicates as a major determinant of cell envelope integrity and provides further validation that lysozyme resistance is intrinsically linked to the modification of enterococcal cell wall polysaccharides. Enterococcus faecalis is a leading cause of health-care-associated infections for which there are limited treatment options. E. faecalis is resistant to several antibiotics and to high concentrations of the human antimicrobial enzyme lysozyme. The molecular mechanisms that mediate lysozyme resistance in E. faecalis are complex and remain incompletely characterized. This work demonstrates that a gene located within the variable region of the enterococcal polysaccharide antigen locus of E. faecalis strain OG1RF (), which is predicted to encode a component of the teichoic acid biosynthesis machinery, is part of the lysozyme resistance circuitry and is important for enterococcal cell wall integrity. These findings suggest that is a potential target for new therapeutic strategies to combat enterococcal infections.
机会性病原体粪肠球菌的致病能力因逃避抗菌剂杀伤的能力而增强。在人抗菌酶溶菌酶存在下,粪肠球菌的存活部分由位点 2 金属蛋白酶 Eep 介导;然而,尚未阐明完整的肠球菌溶菌酶抗性模型。为了更好地理解粪肠球菌中溶菌酶抗性的分子基础,我们分析了通过突变基因而获得对溶菌酶抗性的抑制突变体,该基因是位于肠球菌多糖抗原()基因座可变区的预测的磷壁酸生物合成编码基因。序列比较表明,与表皮葡萄球菌的胞苷-5'-二磷酸(CDP)-甘油:聚(甘油磷酸)甘油磷酸转移酶 TagF 最相似。在野生型和遗传背景下的突变均足以增加粪肠球菌 OG1RF 对溶菌酶的抗性。细胞壁碳水化合物提取物中可检测到的 -乙酰半乳糖胺量减少,并且与负细胞表面电荷减少相关。的靶向破坏也与对抗生素多粘菌素 B 和膜靶向去污剂的敏感性增加以及对类细菌素粘菌素的敏感性降低有关。这项工作表明 是细胞包膜完整性的主要决定因素,并进一步证实溶菌酶抗性与肠球菌细胞壁多糖的修饰内在相关。粪肠球菌是引起与保健相关的感染的主要原因,而这种感染的治疗选择有限。粪肠球菌对几种抗生素和高浓度的人抗菌酶溶菌酶具有抗性。介导粪肠球菌中溶菌酶抗性的分子机制复杂且仍不完全描述。这项工作表明,位于粪肠球菌 OG1RF 菌株的肠球菌多糖抗原基因座的可变区的基因(),预测编码磷壁酸生物合成机制的一部分,是溶菌酶抗性电路的一部分,并且对肠球菌细胞壁完整性很重要。这些发现表明是对抗肠球菌感染的新治疗策略的潜在靶标。